GSK Unit Pauses Chancery Patent Suit For Settlement Talks
By Adam Lidgett · January 26, 2024, 10:01 PM EST
A specialty pharma company majority-owned by GlaxoSmithKline has agreed to stay its Delaware Chancery Court lawsuit against a San Francisco biotech startup it accuses of butting into a university research collaboration...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login